March 16, 2012

Sanofi to Acquire Pluromed, Inc., Expanding its Presence in Biosurgery

- Sanofi to commercialize LeGoo® a highly innovative FDA approved and CE marked gel that provides temporary blood vessel occlusion during surgery -

 

Sanofi to Acquire Pluromed, Inc., Expanding its Presence in Biosurgery
- Sanofi to commercialize LeGoo® a highly innovative FDA approved and CE marked gel that provides temporary blood vessel occlusion during surgery -

Paris, France – March 16, 2012 – Sanofi (EURONEXT: SAN and NYSE: SNY) and Pluromed Inc. announced today that they have entered into a definitive agreement under which Sanofi is to acquire Pluromed Inc., a medical device company based in Woburn, Massachusetts. The acquisition is subject to customary closing conditions.